A new research perspective was published in Oncotarget Volume 14 on April 26, 2023.
Colon cancer (CRC) is one of the most common malignancies and is a leading cause of cancer-related deaths worldwide.
While the tumour microenvironment (TME) supports tumour growth and immune escape through tumour-promoting inflammation, the mechanisms by which the TME promotes CRC are far from being elucidated.
Stromal myo-/fibroblasts (MFs) account for up to 30% of lamina propria cells in the normal human colon and their number is dramatically increased in CRC.
Fibroblasts from cancers, also known as cancer-associated fibroblasts (CAFs), differ from normal colonic MF (N-MFs) and support tumour-promoting inflammation, in part due to increased IL-6 secretion.
CAFs are very abundant in the TME and are among the major cells involved in tumour inflammation and progression.
In this research perspective, researchers Romain Villéger, Marina Chulkina, Randy C Mifflin, Don W Powell, and Irina V Pinchuk from the Université de Poitiers, Penn State Health Milton S Hershey Medical Center and The University of Texas Medical Branch highlight recent data obtained regarding IL-6 regulation in colorectal cancer CAFs through vitamin A (retinol) metabolism, discuss current limitations in our understanding of the mechanisms leading to the CAF pro-inflammatory phenotype, and discuss potential approaches to target CAF retinoid metabolism during CRC treatment.
"While the overall mechanisms responsible for the IL-6 increase within the CRC tumour stroma remain to be elucidated, our study highlights the crucial role of stromal vitamin A pathway in IL-6 regulation."
Source: Impact Journals LLC
The World Cancer Declaration recognises that to make major reductions in premature deaths, innovative education and training opportunities for healthcare workers in all disciplines of cancer control need to improve significantly.
ecancer plays a critical part in improving access to education for medical professionals.
Every day we help doctors, nurses, patients and their advocates to further their knowledge and improve the quality of care. Please make a donation to support our ongoing work.
Thank you for your support.